UCAR T-cell trials for Multiple sclerosis

All UCAR T-cell trials · All Multiple sclerosis trials

Phase breakdown

Recruiting trials studying UCAR T-cell for Multiple sclerosis

• Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
  NCT07507201 · Phase: Early Phase 1 · Ages: 3 Years and older · Sex: All (male and female) · 1 location
• CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
  NCT07305116 · Phase: Phase 1 · Ages: 3 Years and older · Sex: All (male and female) · 1 location
• Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases
  NCT06939166 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study UCAR T-cell for Multiple sclerosis?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.